JPH2 and heart disorder: ARP-100 was used as MMP-2 specific inhibitor already in other studies on heart disease: in isolated hearts, ARP-100 reduced ischemia-reperfusion injury via protection against junctophilin 2 or SERCA (Sarcoplasmic reticulum calcium ATPase) degradation [38, 39].